New research from our group, published in Neuropsychopharmacology: Following a double-blind, placebo-controlled, parallel group design, we utilized an ultra-high field multimodal brain imaging approach and demonstrated that psilocybin (0.17 mg/kg) induced region-dependent alterations in glutamate, which predicted distortions in the subjective experience of one’s self (ego dissolution). Whereas higher levels of medial prefrontal cortical glutamate were… Continue reading How Magic Mushrooms Might Dissolve the Ego Revealed
New research from our group, published in PNAS: In a double-blind, randomised, placebo-controlled study, we show that cannabis increased false memory rates using different false memory methods. The findings have significant legal implications. Read coverage of the publication from Live Science: https://www.livescience.com/cannabis-use-linked-to-false-memories.html
New Rochelle, NY, March 19, 2019—A new study shows that inhaled doses of as little as 2 mg of the synthetic cannabinoid JWH-018 can significantly impair critical thinking and memory, slow reaction times, and increase confusion and dissociation. The results of this placebo controlled, cross-over study are published in Cannabis and Cannabinoid Research, a peer-reviewed… Continue reading Even Low Doses of Synthetic Cannabinoids Can Impair Cognitive Performance
New research from our group provides more evidence that psilocybin, the active ingredient in magic mushrooms, can improve creative thinking, empathy, and subjective well-being. Read more here, here ,and here.
Malin Uthaug, PhD student in our department, recently discussed the ethical considerations of inhaling bufotoxins from Incilius Alvarius. Read her opinions on this practice here